COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,093 Articles (22,658 medRxiv, 8,435 bioRxiv)

Most recent first Previous |  Page 249: Articles 2481-2490  | Next

Natural selection exerted by historical coronavirus epidemic(s): comparative genetic analysis in China Kadoorie Biobank and UK Biobank
Morris, S. C., Lin, K., Millwood, I. Y., Yu, C., Lv, J., Pei, P., Li, L., Sun, D., Davey Smith, G., Chen, Z., Walters, R. G.
10.1101/2024.02.06.579075 — Posted: 2024-02-06
Building Blocks of Understanding: Constructing a Reverse Genetics Platform for studying determinants of SARS-CoV-2 replication.
Olguin-Nava, M., Bohn, P., Hennig, T., Boertlein, C., Gribling-Burrer, A.-S., Schmidt, N., Caliskan, N., Doelken, L., Munschauer, M., Smyth, R. P.
10.1101/2024.02.05.578560 — Posted: 2024-02-06
Second Boost of Omicron SARS-CoV-2 S1 Subunit Vaccine Induced Broad Humoral Immune Responses in Elderly Mice
Kim, E., Khan, M. S., Ferrari, A., Huang, S., Kenniston, T. W., Cassaniti, I., Baldanti, F., Gambotto, A.
10.1101/2024.02.05.578925 — Posted: 2024-02-06
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants
Jain, S., Kumar, S., Lai, L., Linderman, S., Malik, A. A., Ellis, M. L., Godbole, S., Solis, D., Sahoo, M. K., Bechnak, K., Paredes, I., Tanios, R., Kazzi, B., Dib, S. M., Litvack, M. B., Wimalsena, S. T., Ciric, C., Rostad, C., West, R., Teng, I.-T., Wang, D., Kwong, P. D., Rouphael, N., Pinsky, B. A., Douek, D. C., Wrammert, J., Moreno, A., Suthar, M. S.
10.1101/2024.02.03.578771 — Posted: 2024-02-05
Prolonged airway explant culture enables study of health, disease, and viral pathogenesis
Lee-Ferris, R. E., Okuda, K., Galiger, J. R., Schworer, S. A., Rogers, T. D., Dang, H., Gilmore, R., Edwards, C., Nakano, S., Cawley, A. M., Pickles, R. J., Gallant, S. C., Crisci, E., Rivier, L., Hagood, J. S., O'Neal, W. K., Baric, R. S., Grubb, B. R., Boucher, R. C., Randell, S. H.
10.1101/2024.02.03.578756 — Posted: 2024-02-05
DNA Prime-Protein Boost Targeting Conformational Non-RBD Region for Broad Cross-Neutralization
Ma, Y.-F., Chen, K., Xie, B., Zhu, J., He, X., Chen, C., Yang, Y. R., Liu, Y.
10.1101/2024.02.04.578544 — Posted: 2024-02-05
The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming
Paiardi, G., Ferraz, M., Rusnati, M., Wade, R. C.
10.1101/2024.02.05.578888 — Posted: 2024-02-05
Online early supportive psychological intervention for bereaved families during COVID-19: Lessons Learned and Implementation Challenges
Hashemzadeh, M., Jamaloo, S., Shahmohamadi, E., Rahmani, A., Rajabi Damavandi, G., Seyed Mousavi, M., Gharaati Sotoudeh, H., Artounian, V.
10.1101/2024.02.03.24302281 — Posted: 2024-02-05
COVID-19 Trends at The University of Tennessee: Predictive Insights from Raw Sewage SARS-CoV-2 Detection and Evaluation and PMMoV as an Indicator for Human Waste
Li, Y., Ash, K., Alamilla, I., Joyner, D. C., Williams, D. E., McKay, P. J., Green, B., DeBlander, S., North, C., Kara-Murdoch, F., Swift, C., Hazen, T. C.
10.1101/2024.02.03.24302256 — Posted: 2024-02-04
Unreliability in Simulations of COVID-19 Cases and Deaths Based on Transmission Models
Kakeya, H., Itoh, M., Kamijima, Y., Nitta, T., Umeno, Y.
10.1101/2024.02.02.24302123 — Posted: 2024-02-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).